Navigation Links
Genopole(R) to Accompany 7 Companies and a Research lab to BIO Atlanta

EVRY, France, April 23 /PRNewswire/ -- The 2009 edition of the Biotechnology Industry Organization (BIO) Conference and Exhibition will take place in Atlanta from May 18th-20th. Genopole(R) will participate in this major event as part of a delegation from the Paris Ile-de-France Region. Seven of Genopole(R)'s innovative companies (BioQuanta, Drugabilis, GenOptics, Innavirvax, Texcell, Watchfrog and Xentech) and the I-Stem research lab will, attend.

The annual BIO show attracts most of the global stakeholders in the biotech sector and is an event that a biopark like Genopole(R) cannot afford to miss! Since Genopole(R)'s creation in 1998, the cluster has been a regular attendee at an event that delivers true international visibility.

The Paris Ile-de-France region's key biotech players will be well represented at BIO 2009. Alongside the Paris Region Economic Development Agency (ARD), the Genopole(R) Biopark and the Medicen Bio Region will each accompany 7 companies. The Biocitech, Paris Biopark and Cancer Campus bioparks have also joined the delegation.

Genopole(R) members BioQuanta, Drugabilis, GenOptics, Innavirvax, Texcell, Watchfrog and Xentech will be attending BIO this year. "The event is a great opportunity for our companies to present their products, expertise and know-how. The business conventions, seminar sessions and forums are all vectors for meeting future partners and clients", explained Eric Lameignere (Director, Genopole(R) Entreprises).

Resource sharing is a key development theme for bioparks. Naceur Tounekti (Director, Genopole Infrastructure) will give a talk on this subject during the session entitled "Bio-Manufacturing and High-Tech Facilities: How to Share Tools Between Bio-Regions?" (Tuesday May 19th, from 4:00 pm to 5:30 pm- Room B312-Building B).

As a prelude to BIO, the third edition of the "Fast-Track R&D Partnering with France" event will take place on Monday May 18th, from 2:00 pm onwards. The seminar will give over 100 company managers, researchers and academics from across the world an opportunity to identify and initiate R&D collaborations with French partners. This interfacing event is been organized by France's 8 healthcare/biotech clusters (including Medicen from the Paris Region) and is led by Lyonbiopole, in collaboration with the UbiFrance international trade agency and with funding from the French Ministry of Industry.

SOURCE Genopole
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
2. The Pittsburgh Life Sciences Greenhouse Adds New Companies to its Investment Portfolio
3. New White Paper Details Strategies for Biotechnology Companies to Improve EH&S Compliance
4. Beaumont Technology Usability Center To Offer Training For Medical Technology Companies
5. Deloitte Leadership Offers Crucial Convergence Considerations for Life Sciences Companies
6. Michigan Life Science Network to Form Two New Virtual Companies
7. Michigan Life Science Network: Virtual Companies Get Global Reception
8. 2007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies
9. Virtual Life Science Companies Launch and Tour
10. Align Technology, Inc. Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific & Medical Equipment, and Bio-Technology Companies
11. Medical Services Begins Working With United States Companies for Distribution of Its Products
Post Your Comments:
(Date:11/24/2015)... ... 24, 2015 , ... The Academy of Model Aeronautics (AMA), led by its ... as Multirotor Grand Prix, to represent the First–Person View (FPV) racing community. , FPV ... embraced this type of racing and several new model aviation pilots have joined the ...
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... 11,000 post-share consolidation (or 1,100,000 pre-share consolidation) Series ... Warrants") subject to the previously disclosed November 1, ... which will result in the issuance of 365,518 ... issuance of such shares, there will be approximately ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... Inc., on being named to Deloitte's 2015 Technology Fast 500 list of the ... manufactures AcceleDent®, a FDA-cleared, Class II medical device that speeds up orthodontic tooth ...
(Date:11/24/2015)... 24, 2015  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ... company,s president and chief executive officer, will present at the ... in New York City . The presentation ... 1, 2015 at 9:30 a.m. EST. ... website at least 15 minutes prior to the presentation to ...
Breaking Biology Technology:
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... 29, 2015  The J. Craig Venter Institute (JCVI) ... Synthesis and Biosecurity: Lessons Learned and Options for the ... and Human Services guidance for synthetic biology providers has ... --> --> Synthetic biology ... potential to pose unique biosecurity threats. It now is ...
(Date:10/29/2015)... ANN ARBOR, Mich. , Oct. 29, 2015 ... with Eurofins Genomics for U.S. distribution of its ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq ... DNA to enable the preparation of NGS libraries ... in plasma for diagnostic and prognostic applications in ...
Breaking Biology News(10 mins):